Sustainable Practices in Medicinal Chemistry Part 2: Green by Design

Journal of Medicinal Chemistry

Volumn 60, Issue 14, 2017, Pages 5955-5968

  Aliagas, Ignacio ^a   Berger, Raphaëlle ^b   Goldberg, Kristin ^c   Nishimura, Rachel T ^d   Reilly, John ^e   Richardson, Paul ^f   Richter, Daniel ^f   Sherer, Edward C ^b   Sparling, Brian A ^g   Bryan, Marian C ^a  

^a GENENTECH INC   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c ASTRAZENECA   (United Kingdom)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^e NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^f PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^g AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; DRUG;

ARTICLE; DRUG ABSORPTION; DRUG DEVELOPMENT; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG SOLUBILITY; DRUG SYNTHESIS; GREEN CHEMISTRY; HUMAN; LIPOPHILICITY; MEDICINAL CHEMISTRY; MOLECULAR LIBRARY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ACTIVITY RELATION; CHEMISTRY; COMPUTER SIMULATION; HIGH THROUGHPUT SCREENING; PROCEDURES; SYNTHESIS;

CHEMISTRY TECHNIQUES, SYNTHETIC; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; DRUG DISCOVERY; GREEN CHEMISTRY TECHNOLOGY; HIGH-THROUGHPUT SCREENING ASSAYS; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 85026398938     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.6b01837     Document Type: Article

References (92)

1. Constable, D. J. C.; Jimenez-Gonzalez, C.; Henderson, R. K. Perspective on solvent use in the pharmaceutical industry Org. Process Res. Dev. 2007, 11, 133-137 10.1021/op060170h
2. Summerton, L.; Sneddon, H. F.; Jones, L. C.; Clark, J. H. Green and Sustainable Medicinal Chemistry: Methods, Tools and Strategies for the 21st Century Pharmaceutical Industry; The Royal Society of Chemistry: Cambridge, U.K., 2016; pp 1-221.
3. Henderson, R. K.; Jimenez-Gonzalez, C.; Constable, D. J. C.; Alston, S. R.; Inglis, G. G. A.; Fisher, G.; Sherwood, J.; Binks, S. P.; Curzons, A. D. Expanding GSK's solvent selection guide-embedding sustainability into solvent selection starting at medicinal chemistry Green Chem. 2011, 13, 854-862 10.1039/c0gc00918k
4. Jimenez-Gonzalez, C.; Ponder, C. S.; Broxterman, Q. B.; Manley, J. B. Using the right green yardstick: why process mass intensity is used in the pharmaceutical industry to drive more sustainable processes Org. Process Res. Dev. 2011, 15, 912-917 10.1021/op200097d
5. Kjell, D. P.; Watson, I. A.; Wolfe, C. N.; Spitler, J. T. Complexity-based metric for process mass intensity in the pharmaceutical industry Org. Process Res. Dev. 2013, 17, 169-174 10.1021/op3002917
6. Tucker, J. L. Green chemistry, a pharmaceutical perspective Org. Process Res. Dev. 2006, 10, 315-319 10.1021/op050227k
7. Anastas, P. T.; Warner, J. C. Green Chemistry: Theory and Practice; Oxford University Press: Oxford, U.K., 1998; p 30.
8. Dunn, P. J.; Wells, A.; Williams, M. T. Green Chemistry in the Pharmaceutical Industry; Wiley-VCH: Weinheim, Germany, 2010; pp 10-352.
9. Sneddon, H. F. Green Chemistry Strategies for Drug Discovery; The Royal Society of Chemistry: Cambridge, U.K., 2015; Vol. 46, p 14.
10. Abou-Gharbia, M.; Childers, W. E. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 2. Pharma's challenges and their commitment to innovation J. Med. Chem. 2014, 57, 5525-5553 10.1021/jm401564r
11. Bryan, M. C.; Dillon, B.; Hamann, L. G.; Hughes, G. J.; Kopach, M. E.; Peterson, E. A.; Pourashraf, M.; Raheem, I.; Richardson, P.; Richter, D.; Sneddon, H. F. Sustainable practices in medicinal chemistry: current state and future directions J. Med. Chem. 2013, 56, 6007-6021 10.1021/jm400250p
12. Tropsha, A.; Bajorath, J. Computational methods for drug discovery and design J. Med. Chem. 2016, 59, 1-1 10.1021/acs.jmedchem.5b01945
13. Sheridan, R. P.; Zorn, N.; Sherer, E. C.; Campeau, L.-C.; Chang, C.; Cumming, J.; Maddess, M. L.; Nantermet, P. G.; Sinz, C. J.; O'Shea, P. D. Modeling a crowdsourced definition of molecular complexity J. Chem. Inf. Model. 2014, 54, 1604-1616 10.1021/ci5001778
14. Zhou, J. Z. Structure-directed combinatorial library design Curr. Opin. Chem. Biol. 2008, 12, 379-385 10.1016/j.cbpa.2008.02.007
15. Meanwell, N. A. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety Chem. Res. Toxicol. 2011, 24, 1420-1456 10.1021/tx200211v
16. Ortwine, D. F.; Aliagas, I. Physicochemical and DMPK in silico models: facilitating their use by medicinal chemists Mol. Pharmaceutics 2013, 10, 1153-1161 10.1021/mp3006193
17. Feng, J. A.; Aliagas, I.; Bergeron, P.; Blaney, J. M.; Bradley, E. K.; Koehler, M. F. T.; Lee, M.-L.; Ortwine, D. F.; Tsui, V.; Wu, J.; Gobbi, A. An integrated suite of modeling tools that empower scientists in structure- and property-based drug design J. Comput.-Aided Mol. Des. 2015, 29, 511-523 10.1007/s10822-015-9845-4
18. Rankovic, Z. CNS drug design: balancing physicochemical properties for optimal brain exposure J. Med. Chem. 2015, 58, 2584-2608 10.1021/jm501535r
19. Sheridan, R. P.; McMasters, D. R.; Voigt, J. H.; Wildey, M. J. eCounterscreening: using QSAR predictions to prioritize testing for off-target activities and setting the balance between benefit and risk J. Chem. Inf. Model. 2015, 55, 231-238 10.1021/ci500666m
20. Baell, J. B. Broad coverage of commercially available lead-like screening space with fewer than 350,000 compounds J. Chem. Inf. Model. 2013, 53, 39-55 10.1021/ci300461a
21. Kellenberger, E.; Springael, J.-Y.; Parmentier, M.; Hachet-Haas, M.; Galzi, J.-L.; Rognan, D. Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening J. Med. Chem. 2007, 50, 1294-1303 10.1021/jm061389p
22. Ryckmans, T.; Edwards, M. P.; Horne, V. A.; Correia, A. M.; Owen, D. R.; Thompson, L. R.; Tran, I.; Tutt, M. F.; Young, T. Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis Bioorg. Med. Chem. Lett. 2009, 19, 4406-4409 10.1016/j.bmcl.2009.05.062
23. Stumpfe, D.; Bajorath, J. Exploring activity cliffs in medicinal chemistry J. Med. Chem. 2012, 55, 2932-2942 10.1021/jm201706b
24. Cherkasov, A.; Muratov, E. N.; Fourches, D.; Varnek, A.; Baskin, I. I.; Cronin, M.; Dearden, J.; Gramatica, P.; Martin, Y. C.; Todeschini, R.; Consonni, V.; Kuz'min, V. E.; Cramer, R.; Benigni, R.; Yang, C.; Rathman, J.; Terfloth, L.; Gasteiger, J.; Richard, A.; Tropsha, A. QSAR modeling: where have you been? Where are you going to? J. Med. Chem. 2014, 57, 4977-5010 10.1021/jm4004285
25. Gunaydin, H. Probabilistic approach to generating MPOs and its application as a scoring function for CNS drugs ACS Med. Chem. Lett. 2016, 7, 89-93 10.1021/acsmedchemlett.5b00390
26. Segall, M.; Champness, E.; Leeding, C.; Lilien, R.; Mettu, R.; Stevens, B. Applying medicinal chemistry transformations and multiparameter optimization to guide the search for high-quality leads and candidates J. Chem. Inf. Model. 2011, 51, 2967-2976 10.1021/ci2003208
27. Wager, T. T.; Hou, X.; Verhoest, P. R.; Villalobos, A. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties ACS Chem. Neurosci. 2010, 1, 435-449 10.1021/cn100008c
28. Burke, M. D.; Schreiber, S. L. A planning strategy for diversity-oriented synthesis Angew. Chem., Int. Ed. 2004, 43, 46-58 10.1002/anie.200300626
29. Ertl, P.; Schuffenhauer, A. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions J. Cheminf. 2009, 1, 8 10.1186/1758-2946-1-8
30. Brown, D. G.; Boström, J. Analysis of past and present synthetic methodologies on medicinal chemistry: Where have all the new reactions gone? J. Med. Chem. 2016, 59, 4443-4458 10.1021/acs.jmedchem.5b01409
31. Law, J.; Zsoldos, Z.; Simon, A.; Reid, D.; Liu, Y.; Khew, S. Y.; Johnson, A. P.; Major, S.; Wade, R. A.; Ando, H. Y. Route designer: a retrosynthetic analysis tool utilizing automated retrosynthetic rule generation J. Chem. Inf. Model. 2009, 49, 593-602 10.1021/ci800228y
32. Gasteiger, J. Chemoinformatics: achievements and challenges, a personal view Molecules 2016, 21, 151 10.3390/molecules21020151
33. Varnek, A.; Baskin, I. I. Chemoinformatics as a theoretical chemistry discipline Mol. Inf. 2011, 30, 20-32 10.1002/minf.201000100
34. Kenny, P. W.; Leitão, A.; Montanari, C. A. Ligand efficiency metrics considered harmful J. Comput.-Aided Mol. Des. 2014, 28, 699-710 10.1007/s10822-014-9757-8
35. Waring, M. J.; Arrowsmith, J.; Leach, A. R.; Leeson, P. D.; Mandrell, S.; Owen, R. M.; Pairaudeau, G.; Pennie, W. D.; Pickett, S. D.; Wang, J.; Wallace, O.; Weir, A. An analysis of the attrition of drug candidates from four major pharmaceutical companies Nat. Rev. Drug Discovery 2015, 14, 475-486 10.1038/nrd4609
36. Hopkins, A. L.; Keseru, G. M.; Leeson, P. D.; Rees, D. C.; Reynolds, C. H. The role of ligand efficiency metrics in drug discovery Nat. Rev. Drug Discovery 2014, 13, 105-121 10.1038/nrd4163
37. Shultz, M. D. Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters Bioorg. Med. Chem. Lett. 2013, 23, 5980-5991 10.1016/j.bmcl.2013.08.029
38. Leeson, P. D.; Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry Nat. Rev. Drug Discovery 2007, 6, 881-890 10.1038/nrd2445
39. Colmenarejo, G. Compound prioritization in single-concentration screening data using ligand efficiency indexes J. Chem. Inf. Model. 2016, 56, 1705-1713 10.1021/acs.jcim.6b00299
40. Holenz, J. Lead Generation: Methods and Strategies; Wiley-VCH: Weinheim, Germany, 2016; Vol. 68, pp 451-462.
41. Tanaka, D.; Tsuda, Y.; Shiyama, T.; Nishimura, T.; Chiyo, N.; Tominaga, Y.; Sawada, N.; Mimoto, T.; Kusunose, N. A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors J. Med. Chem. 2011, 54, 851-857 10.1021/jm101273e
42. Tarcsay, á.; Nyíri, K.; Keserü, G. M. Impact of lipophilic efficiency on compound quality J. Med. Chem. 2012, 55, 1252-1260 10.1021/jm201388p
43. Segall, M. D. Multi-parameter optimization: identifying high quality compounds with a balance of properties Curr. Pharm. Des. 2012, 18, 1292-1310 10.2174/138161212799436430
44. de la Vega de Leon, A.; Bajorath, J. Matched molecular pairs derived by retrosynthetic fragmentation MedChemComm 2014, 5, 64-67 10.1039/C3MD00259D
45. Griffen, E.; Leach, A. G.; Robb, G. R.; Warner, D. J. Matched molecular pairs as a medicinal chemistry tool J. Med. Chem. 2011, 54, 7739-7750 10.1021/jm200452d
46. Hu, X.; Hu, Y.; Vogt, M.; Stumpfe, D.; Bajorath, J. MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs J. Chem. Inf. Model. 2012, 52, 1138-1145 10.1021/ci3001138
47. Sushko, Y.; Novotarskyi, S.; Körner, R.; Vogt, J.; Abdelaziz, A.; Tetko, I. V. Prediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization process J. Cheminf. 2014, 6, 48 10.1186/s13321-014-0048-0
48. Fernandez, D.; Ghanta, A.; Kauffman, G. W.; Sanguinetti, M. C. Physicochemical features of the hERG channel drug binding site J. Biol. Chem. 2004, 279, 10120-10127 10.1074/jbc.M310683200
49. Cummins, D. J.; Bell, M. A. Integrating everything: the molecule selection toolkit, a system for compound prioritization in drug discovery J. Med. Chem. 2016, 59, 6999-7010 10.1021/acs.jmedchem.5b01338
50. Zhou, J. Z. Chemical Library Design; Humana Press: New York, 2011; pp 3-154.
51. Xing, L.; McDonald, J. J.; Kolodziej, S. A.; Kurumbail, R. G.; Williams, J. M.; Warren, C. J.; O'Neal, J. M.; Skepner, J. E.; Roberds, S. L. Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening J. Med. Chem. 2011, 54, 1211-1222 10.1021/jm101382t
52. Liao, C.; Sitzmann, M.; Pugliese, A.; Nicklaus, M. C. Software and resources for computational medicinal chemistry Future Med. Chem. 2011, 3, 1057-1085 10.4155/fmc.11.63
53. Hu, Q.; Peng, Z.; Sutton, S. C.; Na, J.; Kostrowicki, J.; Yang, B.; Thacher, T.; Kong, X.; Mattaparti, S.; Zhou, J. Z.; Gonzalez, J.; Ramirez-Weinhouse, M.; Kuki, A. Pfizer global virtual library (PGVL): A chemistry design tool powered by experimentally validated parallel synthesis information ACS Comb. Sci. 2012, 14, 579-589 10.1021/co300096q
54. Aliagas, I.; Gobbi, A.; Heffron, T.; Lee, M.-L.; Ortwine, D. F.; Zak, M.; Khojasteh, S. C. A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery J. Comput.-Aided Mol. Des. 2015, 29, 327-338 10.1007/s10822-015-9838-3
55. Lee, M.-L.; Aliagas, I.; Dotson, J.; Feng, J. A.; Gobbi, A.; Heffron, T. DEGAS: Sharing and tracking target compound ideas with external collaborators J. Chem. Inf. Model. 2012, 52, 278-284 10.1021/ci2003297
56. Ritchie, T. J.; Macdonald, S. J. F. The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design? Drug Discovery Today 2009, 14, 1011-1020 10.1016/j.drudis.2009.07.014
57. Skerratt, S. E.; Andrews, M.; Bagal, S. K.; Bilsland, J.; Brown, D.; Bungay, P. J.; Cole, S.; Gibson, K. R.; Jones, R.; Morao, I.; Nedderman, A.; Omoto, K.; Robinson, C.; Ryckmans, T.; Skinner, K.; Stupple, P.; Waldron, G. The discovery of a potent, selective, and peripherally restricted pan-Trk inhibitor (PF-06273340) for the treatment of pain J. Med. Chem. 2016, 59, 10084-10099 10.1021/acs.jmedchem.6b00850
58. Kulagowski, J. J.; Blair, W.; Bull, R. J.; Chang, C.; Deshmukh, G.; Dyke, H. J.; Eigenbrot, C.; Ghilardi, N.; Gibbons, P.; Harrison, T. K.; Hewitt, P. R.; Liimatta, M.; Hurley, C. A.; Johnson, A.; Johnson, T.; Kenny, J. R.; Bir Kohli, P.; Maxey, R. J.; Mendonca, R.; Mortara, K.; Murray, J.; Narukulla, R.; Shia, S.; Steffek, M.; Ubhayakar, S.; Ultsch, M.; van Abbema, A.; Ward, S. I.; Waszkowycz, B.; Zak, M. Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors J. Med. Chem. 2012, 55, 5901-5921 10.1021/jm300438j
59. Zak, M.; Mendonca, R.; Balazs, M.; Barrett, K.; Bergeron, P.; Blair, W. S.; Chang, C.; Deshmukh, G.; DeVoss, J.; Dragovich, P. S.; Eigenbrot, C.; Ghilardi, N.; Gibbons, P.; Gradl, S.; Hamman, C.; Hanan, E. J.; Harstad, E.; Hewitt, P. R.; Hurley, C. A.; Jin, T.; Johnson, A.; Johnson, T.; Kenny, J. R.; Koehler, M. F. T.; Bir Kohli, P.; Kulagowski, J. J.; Labadie, S.; Liao, J.; Liimatta, M.; Lin, Z.; Lupardus, P. J.; Maxey, R. J.; Murray, J. M.; Pulk, R.; Rodriguez, M.; Savage, S.; Shia, S.; Steffek, M.; Ubhayakar, S.; Ultsch, M.; van Abbema, A.; Ward, S. I.; Xiao, L.; Xiao, Y. Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2 J. Med. Chem. 2012, 55, 6176-6193 10.1021/jm300628c
60. Gao, H.; Shanmugasundaram, V.; Lee, P. Estimation of aqueous solubility of organic compounds with QSPR approach Pharm. Res. 2002, 19, 497-503 10.1023/A:1015103914543
61. Lee, P. H.; Cucurull-Sanchez, L.; Lu, J.; Du, Y. J. Development of in silico models for human liver microsomal stability J. Comput.-Aided Mol. Des. 2007, 21, 665-673 10.1007/s10822-007-9124-0
62. Birch, A. M.; Birtles, S.; Buckett, L. K.; Kemmitt, P. D.; Smith, G. J.; Smith, T. J. D.; Turnbull, A. V.; Wang, S. J. Y. Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor J. Med. Chem. 2009, 52, 1558-1568 10.1021/jm801507v
63. Galloway, W. R. J. D.; Spring, D. R. Towards drugging the 'undruggable': enhancing the scaffold diversity of synthetic small molecule screening collections using diversity-oriented synthesis Diversity-Oriented Synth. 2013, 1, 21-28 10.2478/dos-2013-0001
64. Ibbeson, B. M.; Laraia, L.; Alza, E.; O' Connor, C. J.; Tan, Y. S.; Davies, H. M. L.; McKenzie, G.; Venkitaraman, A. R.; Spring, D. R. Diversity-oriented synthesis as a tool for identifying new modulators of mitosis Nat. Commun. 2014, 5, 3155 10.1038/ncomms4155
65. O' Connor, C. J.; Beckmann, H. S. G.; Spring, D. R. Diversity-oriented synthesis: producing chemical tools for dissecting biology Chem. Soc. Rev. 2012, 41, 4444-4456 10.1039/c2cs35023h
66. Rajarathinam, B.; Kumaravel, K.; Vasuki, G. Green chemistry oriented multi-component strategy to hybrid heterocycles RSC Adv. 2016, 6, 73848-73852 10.1039/C6RA11543H
67. Tan, D. S. Diversity-oriented synthesis: exploring the intersections between chemistry and biology Nat. Chem. Biol. 2005, 1, 74-84 10.1038/nchembio0705-74
68. Marcaurelle, L. A.; Comer, E.; Dandapani, S.; Duvall, J. R.; Gerard, B.; Kesavan, S.; Lee, M. D.; Liu, H.; Lowe, J. T.; Marie, J.-C.; Mulrooney, C. A.; Pandya, B. A.; Rowley, A.; Ryba, T. D.; Suh, B.-C.; Wei, J.; Young, D. W.; Akella, L. B.; Ross, N. T.; Zhang, Y.-L.; Fass, D. M.; Reis, S. A.; Zhao, W.-N.; Haggarty, S. J.; Palmer, M.; Foley, M. A. An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors J. Am. Chem. Soc. 2010, 132, 16962-16976 10.1021/ja105119r
69. Comer, E.; Beaudoin, J. A.; Kato, N.; Fitzgerald, M. E.; Heidebrecht, R. W.; Lee, M. d.; Masi, D.; Mercier, M.; Mulrooney, C.; Muncipinto, G.; Rowley, A.; Crespo-Llado, K.; Serrano, A. E.; Lukens, A. K.; Wiegand, R. C.; Wirth, D. F.; Palmer, M. A.; Foley, M. A.; Munoz, B.; Scherer, C. A.; Duvall, J. R.; Schreiber, S. L. Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agents J. Med. Chem. 2014, 57, 8496-8502 10.1021/jm500994n
70. Kato, N.; Comer, E.; Sakata-Kato, T.; Sharma, A.; Sharma, M.; Maetani, M.; Bastien, J.; Brancucci, N. M.; Bittker, J. A.; Corey, V.; Clarke, D.; Derbyshire, E. R.; Dornan, G. L.; Duffy, S.; Eckley, S.; Itoe, M. A.; Koolen, K. M. J.; Lewis, T. A.; Lui, P. S.; Lukens, A. K.; Lund, E.; March, S.; Meibalan, E.; Meier, B. C.; McPhail, J. A.; Mitasev, B.; Moss, E. L.; Sayes, M.; Van Gessel, Y.; Wawer, M. J.; Yoshinaga, T.; Zeeman, A.-M.; Avery, V. M.; Bhatia, S. N.; Burke, J. E.; Catteruccia, F.; Clardy, J. C.; Clemons, P. A.; Dechering, K. J.; Duvall, J. R.; Foley, M. A.; Gusovsky, F.; Kocken, C. H. M.; Marti, M.; Morningstar, M. L.; Munoz, B.; Neafsey, D. E.; Sharma, A.; Winzeler, E. A.; Wirth, D. F.; Scherer, C. A.; Schreiber, S. L. Diversity-oriented synthesis yields novel multistage antimalarial inhibitors Nature 2016, 538, 344-349 10.1038/nature19804
71. Dandapani, S.; Germain, A. R.; Jewett, I.; le Quement, S.; Marie, J.-C.; Muncipinto, G.; Duvall, J. R.; Carmody, L. C.; Perez, J. R.; Engel, J. C.; Gut, J.; Kellar, D.; Siqueira-Neto, J. L.; McKerrow, J. H.; Kaiser, M.; Rodriguez, A.; Palmer, M. A.; Foley, M.; Schreiber, S. L.; Munoz, B. Diversity-oriented synthesis yields a new drug lead for treatment of chagas disease ACS Med. Chem. Lett. 2014, 5, 149-153 10.1021/ml400403u
72. Ganesan, A.; Coote, M. L.; Barakat, K. Molecular dynamics-driven drug discovery: leaping forward with confidence Drug Discovery Today 2017, 22, 249-269 10.1016/j.drudis.2016.11.001
73. Ooms, F. Molecular modeling and computer aided drug design. examples of their applications in medicinal chemistry Curr. Med. Chem. 2000, 7, 141-158 10.2174/0929867003375317
74. Evenäs, J.; Edfeldt, F.; Lepistö, M.; Svitacheva, N.; Synnergren, A.; Lundquist, B.; Gränse, M.; Rönnholm, A.; Varga, M.; Wright, J.; Wei, M.; Yue, S.; Wang, J.; Li, C.; Li, X.; Chen, G.; Liao, Y.; Lv, G.; Tjörnebo, A.; Narjes, F. HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase Bioorg. Med. Chem. Lett. 2014, 24, 1315-1321 10.1016/j.bmcl.2014.01.050
75. LaPlante, S. R.; Forgione, P.; Boucher, C.; Coulombe, R.; Gillard, J.; Hucke, O.; Jakalian, A.; Joly, M.-A.; Kukolj, G.; Lemke, C.; McCollum, R.; Titolo, S.; Beaulieu, P. L.; Stammers, T. Enantiomeric atropisomers inhibit HCV polymerase and/or HIV matrix: characterizing hindered bond rotations and target selectivity J. Med. Chem. 2014, 57, 1944-1951 10.1021/jm401202a
76. Kettle, J. G.; Alwan, H.; Bista, M.; Breed, J.; Davies, N. L.; Eckersley, K.; Fillery, S.; Foote, K. M.; Goodwin, L.; Jones, D. R.; Käck, H.; Lau, A.; Nissink, J. W. M.; Read, J.; Scott, J. S.; Taylor, B.; Walker, G.; Wissler, L.; Wylot, M. Potent and selective inhibitors of MTH1 probe its role in cancer cell survival J. Med. Chem. 2016, 59, 2346-2361 10.1021/acs.jmedchem.5b01760
77. Cernak, T.; Dykstra, K. D.; Tyagarajan, S.; Vachal, P.; Krska, S. W. The medicinal chemist's toolbox for late stage functionalization of drug-like molecules Chem. Soc. Rev. 2016, 45, 546-576 10.1039/C5CS00628G
78. Sherer, E. C.; Lee, C. H.; Shpungin, J.; Cuff, J. F.; Da, C.; Ball, R.; Bach, R.; Crespo, A.; Gong, X.; Welch, C. J. Systematic approach to conformational sampling for assigning absolute configuration using vibrational circular dichroism J. Med. Chem. 2014, 57, 477-494 10.1021/jm401600u
79. Rücker, C.; Rücker, G.; Bertz, S. H. Organic synthesis-art or science? J. Chem. Inf. Comput. Sci. 2004, 44, 378-386 10.1021/ci030415e
80. Li, J.; Eastgate, M. D. Current complexity: a tool for assessing the complexity of organic molecules Org. Biomol. Chem. 2015, 13, 7164-7176 10.1039/C5OB00709G
81. Allu, T. K.; Oprea, T. I. Rapid evaluation of synthetic and molecular complexity for in silico chemistry J. Chem. Inf. Model. 2005, 45, 1237-1243 10.1021/ci0501387
82. Barone, R.; Chanon, M. A new and simple approach to chemical complexity. application to the synthesis of natural products J. Chem. Inf. Comput. Sci. 2001, 41, 269-272 10.1021/ci000145p
83. Bertz, S. H. The first general index of molecular complexity J. Am. Chem. Soc. 1981, 103, 3599-3601 10.1021/ja00402a071
84. Bertz, S. H. Complexity of synthetic reactions. The use of complexity indices to evaluate reactions, transforms and disconnections New J. Chem. 2003, 27, 860-869 10.1039/b210843g
85. Erlanson, D. A.; Fesik, S. W.; Hubbard, R. E.; Jahnke, W.; Jhoti, H. Twenty years on: the impact of fragments on drug discovery Nat. Rev. Drug Discovery 2016, 15, 605-619 10.1038/nrd.2016.109
86. Hendrickson, J. B.; Huang, P.; Toczko, A. G. Molecular complexity: a simplified formula adapted to individual atoms J. Chem. Inf. Model. 1987, 27, 63-67 10.1021/ci00054a004
87. Leach, A. R.; Hann, M. M. Molecular complexity and fragment-based drug discovery: ten years on Curr. Opin. Chem. Biol. 2011, 15, 489-496 10.1016/j.cbpa.2011.05.008
88. Schuffenhauer, A.; Brown, N.; Selzer, P.; Ertl, P.; Jacoby, E. Relationships between molecular complexity, biological activity, and structural diversity J. Chem. Inf. Model. 2006, 46, 525-535 10.1021/ci0503558
89. von Korff, M.; Sander, T. In Chaos and Complex Systems, Proceedings of the 4th International Interdisciplinary Chaos Symposium; Stavrinides, G. S.; Banerjee, S.; Caglar, H. S.; Ozer, M., Eds.; Springer: Berlin, 2013; pp 301-306.
90. Whitlock, H. W. On the structure of total synthesis of complex natural products J. Org. Chem. 1998, 63, 7982-7989 10.1021/jo9814546
91. Hack, M. D.; Rassokhin, D. N.; Buyck, C.; Seierstad, M.; Skalkin, A.; ten Holte, P.; Jones, T. K.; Mirzadegan, T.; Agrafiotis, D. K. Library enhancement through the wisdom of crowds J. Chem. Inf. Model. 2011, 51, 3275-3286 10.1021/ci200446y
92. Rastogi, T.; Leder, C.; Kümmerer, K. Re-designing of existing pharmaceuticals for environmental biodegradability: a tiered approach with β-blocker propranolol as an example Environ. Sci. Technol. 2015, 49, 11756-11763 10.1021/acs.est.5b03051